Shanghai Pharmaceuticals Holding to Divest 30% Stake in Sino-American Shanghai Squibb Through Public Listing

Stock News02-04 17:42

Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) has announced its intention to publicly list for sale its entire 30% equity stake in the joint venture Sino-American Shanghai Squibb Pharmaceutical Co., Ltd. via a property rights exchange. The minimum listing price for the stake has been set at no less than 1.023 billion yuan. Following the completion of this transaction, the company will no longer hold any shares in Sino-American Shanghai Squibb. This divestment is not expected to have a material impact on the company's routine operations or financial standing. The move is aimed at safeguarding state-owned assets and maximizing their value, aligning with the strategic interests of the company and its shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment